Analyst · GSK plc (GSK) | Ratings, Price Targets & Consensus

Analyst Consensus

Hold1 analysts

Hold

Updated Aug 24, 2026

Total Analysts1

Buy

9

Hold

16

Sell

4

Ratings

Updated Aug 24, 2026

Overall Rating

A-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$52.41

Median Target+1.13%

$53.00

Potential upside vs current price

DCF Value+154.15%

$133.20

Potential upside vs current price

Current Stock Price

$52.41

Median Target+1.13%

$53.00

Potential upside vs current price

DCF Value+154.15%

$133.20

Potential upside vs current price

Analyst Consensus

Hold1 analysts

Hold

Updated Aug 24, 2026

Total Analysts1

Buy

9

Hold

16

Sell

4

Ratings

Updated Aug 24, 2026

Overall Rating

A-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$52.41

Median Target+1.13%

$53.00

Potential upside vs current price

DCF Value+154.15%

$133.20

Potential upside vs current price

Current Stock Price

$52.41

Median Target+1.13%

$53.00

Potential upside vs current price

DCF Value+154.15%

$133.20

Potential upside vs current price